Periodontal inflamed surface area and C-reactive protein as predictors of HbA1c:a study in Indonesia by Susanto, Hendri et al.
  
 University of Groningen
Periodontal inflamed surface area and C-reactive protein as predictors of HbA1c
Susanto, Hendri; Nesse, Willem; Dijkstra, Pieter U.; Hoedemaker, Evelien; van Reenen,





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2012
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Susanto, H., Nesse, W., Dijkstra, P. U., Hoedemaker, E., van Reenen, Y. H., Agustina, D., ... Abbas, F.
(2012). Periodontal inflamed surface area and C-reactive protein as predictors of HbA1c: a study in
Indonesia. Clinical Oral Investigations, 16(4), 1237-1242. https://doi.org/10.1007/s00784-011-0621-0
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
ORIGINAL ARTICLE
Periodontal inflamed surface area and C-reactive protein
as predictors of HbA1c: a study in Indonesia
Hendri Susanto & Willem Nesse & Pieter U. Dijkstra &
Evelien Hoedemaker & Yvonne Huijser van Reenen &
Dewi Agustina & Arjan Vissink & Frank Abbas
Received: 2 July 2011 /Accepted: 2 October 2011 /Published online: 20 October 2011
# The Author(s) 2011. This article is published with open access at Springerlink.com
Abstract Periodontitis may exert an infectious and inflam-
matory burden, evidenced by increased C-reactive protein
(CRP). This burden may impair blood glucose control
(HbA1c). The aim of our study was to analyze whether
periodontitis severity as measured with the periodontal
inflamed surface area (PISA) and CRP predict HbA1c
levels in a group of healthy Indonesians and a group of
Indonesians treated for type 2 diabetes mellitus (DM2). A
full-mouth periodontal examination, including probing
pocket depth, gingival recession, clinical attachment loss,
plaque index and bleeding on probing, was performed in
132 healthy Indonesians and 101 Indonesians treated for
DM2. Using these data, PISA was calculated. In addition,
HbA1c and CRP were analyzed. A validated questionnaire
was used to assess smoking, body mass index (BMI),
education and medical conditions. In regression analyses, it
was assessed whether periodontitis severity and CRP
predict HbA1c, controlling for confounding and effect
modification (i.e., age, sex, BMI, pack years, and educa-
tion). In healthy Indonesians, PISA and CRP predicted
HbA1c as did age, sex, and smoking. In Indonesians treated
for DM2, PISA did not predict HbA1c. Periodontitis may
impair blood glucose regulation in healthy Indonesians in
conjunction with elevated CRP levels. The potential effect
of periodontitis on glucose control in DM2 patients may be
masked by DM2 treatment. Clinical relevance: periodontitis
may impair blood glucose control through exerting an
inflammatory and infectious burden evidenced by increased
levels of CRP.
Keywords Periodontitis . Periodontal inflamed surface
area/PISA . HbA1c . Type 2 diabetes mellitus
Introduction
Periodontal inflamed surface area (PISA) quantifies the
amount of inflamed periodontal tissue and is supposed to
quantify the inflammatory and infectious burden resulting
from periodontitis [1]. Periodontitis may cause an inflam-
matory burden through the production of local inflamma-
tory mediators entering the systemic circulation. This
inflammatory burden is evidenced by increased serum C-
reactive protein (CRP) levels found in patients suffering
from periodontitis [2–7].
Periodontitis may also cause an infectious burden through
bacteria and their products entering the systemic circulation.
This burden may endanger overall health by for example
causing atherosclerosis [8] and cardiovascular diseases [9].
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Circulating oral bacteria and lipopolysacharides are also able
to stimulate hepatocytes to secrete CRP [10–12]. Thus,
increased levels of CRP associated with periodontitis may be
considered as a common pathway for both the inflammatory
and infectious burden resulting from periodontitis.
The high levels of CRP accompanying periodontitis,
may lead to insulin resistance and thereby to poor control of
blood glucose in type 2 diabetes mellitus (DM2) and
healthy subjects [13–16] resulting in increased levels of
glycated hemoglobin (HbA1c) [17, 18]. Accordingly, high
levels of CRP are correlated with increased HbA1c levels in
DM2 patients [19, 20]. Increased CRP levels have also
been associated with an increased risk of cardiovascular
disease (CVD) in DM2 patients, the major cause of the
increased mortality in DM2 patients [21, 22].
Given the importance of blood glucose control in
preventing CVD in DM2 patients, relatively few studies
assessed whether the specific combination of periodontitis
and CRP as a reflection of inflammatory burden, predict
HbA1c levels [23, 24]. Furthermore, no study has investi-
gated this issue in Indonesia while this country is in the top
ten of countries with the highest prevalence of DM (at
5.7%) in the world in 2005. It has been estimated that by
the year 2030, the prevalence of DM in Indonesia will be
about 10%, corresponding with 20 million DM patients
[25, 26]. In addition to a high DM prevalence, a high
prevalence of periodontitis has been reported in Indonesia
[27]. Finally, depending on the definition used, our
previous study showed that Indonesian DM2 patients have
a prevalence of periodontitis at 72% to 93% and an
increased severity of periodontitis [28]. Therefore, the aim
of this study was to assess whether periodontitis severity, as
measured with the PISA method and CRP predict HbA1c
levels in healthy Indonesians and Indonesian treated for
DM2 patients.
Materials and methods
The participants in this study were recruited from three
different sites, namely (1) the Internal Medicine Department
Dr. Sardjito Hospital, Yogjakarta, 2) Prof. Soedomo Dental
Hospital, Faculty of Dentistry, Gadjah Mada University,
Yogjakarta, and 3) Diabetes Center of Jogjakarta International
Hospital, Yogjakarta, Indonesia. All participants had to be
aged ≥18 years and had to have ≥8 remaining teeth. The latter
inclusion criteria was proposed prior to commencing the
study since current inflammatory burden posed by
periodontitis requires the presence of at least a minimum
number of teeth affected by periodontitis. This study was
approved by the Ethical Committee for Research of the
Medical Faculty of Gadjah Mada University, Yogjakarta,
Indonesia.
All participants completed a validated general health
assessment questionnaire [29, 30] to check for other
medical conditions that might be a risk factor for
periodontitis. Information on age, gender, height and
weight (for body mass index (BMI) calculation), education,
and smoking were obtained from each participant.
All participants underwent a periodontal examination
including periodontal probing pocket depth (PD), gingival
recession, plaque score, and bleeding on probing (BOP)
measurements by trained and calibrated examiners (HS,
YHR, and EH). All measurements were performed on all
teeth, on six sites per tooth using a manual periodontal
color-coded standard probe (Dentsply™, London, UK).
Clinical attachment loss (AL) was defined as the
distance from the cementoenamel junction to the bottom
of the pocket/sulcus and calculated as the mathematical
sum of the PD and gingival recession measurements [31].
Measurements were made in millimeters and were rounded
off to the nearest millimeter. BOP was recorded as either
present or absent within 30 s of probing at six sites per
tooth. Plaque score was defined as being present or absent
at six points on each tooth [32]. The number of missing
teeth was also recorded.
Periodontitis extent and severity were operationalized
using a variety of methods, all of which are currently used in
literature studying the association between periodontitis and
other diseases. All measurements were calculated using
conventional clinical measurements obtained during the full-
mouth periodontal examination (HS andWN). The number of
sites with probing PD of ≥4, ≥5, and ≥6 mm, the numbers of
sites with clinical AL of ≥3, ≥4, ≥5, and ≥6 mm, mean PD,
mean AL [33], and the percentage of sites with BOP were
calculated. Additionally, a recently introduced measure of
periodontitis severity, the PISA [1] was calculated, PISA
quantifies the amount of inflamed periodontal tissue, and it is
suggested that PISA thereby quantifies the inflammatory
burden exerted by periodontitis [1].
Finally, all participants underwent a venapuncture to
obtain a blood sample. Both blood glucose (fasting blood
glucose), determined by glucose oxidase enzymatic
method, and glycosilated/glycated hemoglobin (HbA1c)
values, determined using low pressure cation ion ex-
change chromatography (DIASTAT™, Bio-Rad, USA),
were determined for all participants. Additionally, CRP,
determined by a high-sensitivity chemiluminescent
immunometris assay (Immulite 2000™, Diagnostic Prod-
ucts Corp., Los Angeles, CA, USA), were determined for
all participants.
Statistical analysis
Differences in periodontitis severity between DM2 and
healthy subjects were analyzed first using univariate
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analyses (independent sample t test, Mann–Whitney U test,
or Chi-square test as appropriate). Likewise, differences in
potential predictors of periodontitis (age, gender, BMI,
education, smoking, plaque score, number of teeth, ethnic-
ity, and other medical conditions) between DM2 patients
and healthy subjects were tested for significance using
univariate analyses. Since periodontitis severity was oper-
ationalized in 12 different ways, significance level α of
0.05 was corrected for multiple comparisons according to
the Bonferroni–Holm method.
To assess periodontitis and CRP as potential predictors
of HbA1c in subjects with and without DM2, a multiple
linear regression analysis was performed, using a
backward stepwise method. HbA1c was the dependent.
As independent variables, i.e., predictors of HbA1c: age,
sex, BMI, pack years, education, CRP, and all measures
of periodontitis severity. The latter were introduced in
the model one by one. Statistics were calculated using
SPSS 16.0.
Results
In a total of 101 participants, 40 men and 61 women, with a
mean age of 54 years treated for DM2, diagnosed according
to World Health Organization criteria [34] were included
(Table 1). Most of the participants were of Javanese origin
(93.0%). The mean BMI in this group was 25.5, labeling
them as being overweight according to the World Health
Organization classification (overweight—BMI, 23–27.5)
[35]. The DM2 patients had an average of 24 teeth with a
mean plaque score of 91% (Table 2). The mean HbA1c in
the DM2 group was 8.9%. In addition, a total of 132
healthy controls was enrolled, 34 men and 98 women, with
a mean age of 48 years. Again, the healthy subjects were
mainly of Javanese origin (90%) and were on average
ranked as being overweight according to the BMI index for
Asian populations (BMI, 24.4) [35]. The healthy subjects
had an average of 26 teeth and a mean plaque score of 93%.
The average HbA1c level of this group was 5.5% (below
6.5% classified as healthy/non diabetic).
The severity of periodontitis was significantly higher
in participants with DM2 when compared to controls,
again independent of the method used to operationalize
periodontitis severity (Table 2). In the DM2 patients, none
of the measures of periodontitis severity predicted HbA1c.
Only SES (β=−0.752; 95% CI=−1.345 to −0.158) was a
predictor of HbA1c, (r2 of 6.0%; data not shown). By
contrast, in healthy Indonesians, PISA (β=0.0004; 95%
CI=0.00004-0.00076) was a predictor of HbA1c together
with age, sex, smoking and CRP, (r2=21%) in the model
(Table 3).
Table 1 Characteristics of the
participants
p values were Bonferroni–Holm
corrected. A p value of <0.05
was considered
statistically significant
p probability, BMI body mass
index, CRP C-reactive protein,
DM2 diabetes mellitus type
2, HbA1c glycated hemoglobin,
IQR interquartile range, n
number of participants, NA not
applicable, SD standard
deviation, low, elementary and
junior school (education),
middle high school (education),
high university (education)
aResult of Chi-square test
bResult of Mann–Whitney U test;
other results are the results
of the independent samples t test
Variables DM2 (n=101) Healthy controls (n=132) p value
Demography
Age (years) mean (SD) 54.4 (10.7) 47.9 (10.1) <0.001
Smoking (pack year) median (IQR)b 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.109
BMI (kg/m2) mean (SD) 25.5(4.2) 24.4 (3.8) 0.054
Java origin (n (%))a 94 (93%) 119 (90%) 0.431
Gender (n (%))a <0.05
Male 40 (40%) 34 (26%)
Female 60 (60%) 98 (74%)
Education (n (%))a 2.18 (0.79) 2.13 (0.77) 0.662
Low (6–9 years) 32 (24%) 24 (23%)
Middle (9–12 years) 51 (39%) 34 (34%)
High (12–17 years) 49 (37%) 43 (43%)
Hypertension (yes) (n (%))a 26 (26%) 24 (18%) 0.164
Medication (n (%))
Sulfonylurea 55 (54%) NA NA
Insulin 41 (41%) NA
Metformin 37 (37%) NA
Acarbose 33 (33%) NA
Laboratory serum markers
HbA1c (%) mean (SD) 8.9 (2.4) 5.5 (0.4) <0.001
CRP (mg/l) median (IQR)b 2.8(1.6–7.0) 1.1 (0.6–2.3) <0.001
Clin Oral Invest (2012) 16:1237–1242 1239
Discussion
This study showed that PISA is a predictor of HbA1c, in
conjunction with CRP, age, sex, and smoking, in healthy
Indonesians. Thus, periodontitis may play a role in
inducing impaired blood glucose control. Indeed, there is
evidence that periodontitis may induce insulin resistance
[18]. It is thought that periodontitis exerts an inflammatory
and infectious burden as evidenced by increased levels of
CRP [3, 5, 6] which may increase HbA1c levels [19, 20,
36]. Accordingly, PISA predicted HbA1c together with
CRP.
It is striking that out of the various methods to
operationalize periodontitis severity, only the PISA
emerged as a predictor of HbA1c. The other methods for
determining the severity and extent of periodontitis did not
contribute significantly to a model that predicts HbA1c. It
may be that the PISA is a predictor of HbA1c because it
reflects the amount of inflamed periodontal tissue, thereby
predicting both infectious and inflammatory burden more
accurately than other methods used to operationalize
periodontitis [1, 18].
In Indonesian DM2 patients, no measure for periodonti-
tis severity predicted HbA1c. The observed differences
between DM2 patients and healthy Indonesians may be
explained as follows. First, almost all DM2 patients used a
combination of medication to control blood sugar, drugs
that healthy Indonesians obviously did not take [37]. Use
such medication may mask an effect of periodontitis on the
HbA1c level in DM2 patients. Second, DM2 patients may
have dietary restrictions, e.g., avoiding sugar rich foods.
Such a diet may impact blood sugar and may mask an
affect of periodontitis on HbA1c level.
Previously, a dose–response relationship was observed
between PISA and HbA1c in DM2 patients from the
Caribbean island, Curacao [18]. Additionally, an increased
HbA1c was observed to be associated with increased
severity of periodontitis [38]. Moreover, it has been
Table 2 Periodontal status of
healthy controls and DM2
p values were Bonferroni–Holm
corrected. A p value of <0.05
was considered statistically
significant
p probability, BOP bleeding on
probing, AL clinical attachment
loss, DM2 diabetes mellitus
type 2, IQR interquartile range,
n number of participants, PISA
periodontal inflamed surface
area, PD probing pocket depth,
SD standard deviation
aResult of Chi-square test
bResult of Mann–Whitney U test;
other results are the results
of the independent samples t test
Variables Healthy controls (n=132) DM2 (n=101) p value
Periodontal prevalence (n (%))a
PD (≥4 mm) and AL (≥3 mm) 89 (67%) 89 (88%) <0.001
PD (≥5 mm) AL (≥2 mm) 43 (33%) 67 (66%) <0.001
Periodontal severity (median (IQR))b
PISA (mm2) 83.9 (35.2–206.4) 170.4 (91.5–392.6) <0.017
AL (mm) 1.8 (1.7–2.3) 2.4 (2.0–3.4) <0.001
PD (mm) 1.7 (1.6–1.9) 1.9 (1.7–2.4) <0.001
Number of sites (median (IQR))b
AL (≥3 mm) 30.0 (17.0–47.0) 54.0 (32.50–74.50) <0.001
AL (≥4 mm) 5.0 (1.0–15.8) 25.0 (9.0–48.0) <0.001
AL (≥5 mm) 1.0 (0.0–4.8) 13.0 (2.0–31.50) <0.001
AL (≥6 mm) 0.0 (0.0–1.0) 4.0 (0.0–19.5) <0.001
PD (≥4 mm) 2.0 (0.0–4.0) 6.0 (2.0–18.0) <0.001
PD (≥5 mm) 0.0 (0.0–1.0) 2.0 (0.0–8.0) <0.001
PD (≥6 mm) 0.0 (0.0–0.0) 1.0 (0.0–3.0) 0.001
BOP (n (%)) 9.0 (4.0–20.0) 18.0 (10.0–31.5) <0.001
Mean (SD)
Plaque score (%) 93% (8.5) 91% (7.9) 0.059
Number of teeth 25.7 (4.7) 23.6 (6.2) 0.005
Table 3 Results of the multiple linear regression analysis healthy
control group
Model predictors β p value of β R2 95% confidence
interval of β
Model 0.21
PISA (mm2)a 0.0004 <0.05 0.00004 to 0.00076
Age (year) 0.0105 0.001 0.00431 to 0.01674
Male/female
(1/0)
−0.1378 0.08 −0.29170 to 0.01595
Smoking
(pack year)
0.0086 0.07 −0.00074 to 0.01805
CRP (mg/l) 0.0212 0.06 −0.00093 to 0.04343
Constant 4.9591 <0.001 4.62706 to 5.29121
A p value of <0.05 was considered statistically significant. Dependent
variable—HbA1c; independent variables: PISA, age, sex, and smoking/
pack years. Constant
p probability, β unstandardized coefficient, HbA1c glycated hemoglobin,
periodontal inflamed surface area, CRP C-reactive protein
a Other measures of periodontitis severity were not predictors of HbA1c
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reported that periodontal treatment leads to improvement of
glycemic control in DM2 patients [39]. These findings
appear to be in sharp contrast with the findings in this
study, i.e., PISA is not a predictor of HbA1c in a group of
Indonesian DM2 patients. The difference between the
current study and the study in Curacao [18] could be
explained by differences in populations. First, substantial
differences were observed in the frequency of antidiabetics
used between DM2 from Indonesia and Curacao. Acarbose
(33% vs. 5%), insulin (41% vs. 21%), and sulfonylurea
(54% vs. 35%) were used more often in DM2 patients from
Indonesia, while metformin 37 vs. 67% was used more
often in DM2 patients from Curacao. Additionally, 16% of
DM2 patients from Curacao used tolbutamide, while none
of Indonesian DM2 patients used it. Differences in the
frequency of antidiabetics used, may also explain the
differences in results. As reported by Teeuw et al. [38]
and Simpson et al. [39], HbA1c levels might be affected by
the treatment DM2 patients receive, i.e., both the drugs they
use and the periodontal treatment the patients have
received. Thus, a drug-related reduction in HbA1c levels
in patients not yet adequately periodontally treated might be
responsible for the failure of PISA to predict HbA1c levels
in our Indonesian DM2. Second, the average BMI of DM2
patients from Curacao was 31 while the average BMI of
Indonesian DM2 patients was substantially lower, namely
25. BMI may be an effect modifier, i.e., a higher BMI may
increase the potential insulin resistance inducing effect of
periodontitis in DM2 patients [40, 41]. Third, there is clear
difference in ethnicity between the two groups, i.e., one
from Indonesia of Javanese origin and the other from
Curacao of African-American origin. Possible differences
in (health promoting) behavior, diet, and genes, related to
the differences in ethnicity, may be another explanation for
the differences in results [42, 43].
Conclusions
PISA was shown to be a predictor of HbA1c in healthy
Indonesians in conjunction with CRP, age, sex, and
smoking. This implies that periodontitis might contribute
to insulin resistance through the inflammatory and infec-
tious burden leading to DM2. In Indonesian patients,
treated for DM2, PISA was not able to predict HbA1c.
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